T2 - Shared experiences and lessons learnt during the pandemic: Mental health challenges



Prof. Parisa Aslani (FIP Vice President, Australia)


As the pandemic continues to severely disrupt healthcare systems and economies worldwide, key stakeholders in global health — including members of the pharmacy profession — are playing a crucial role in fighting the virus. COVID-19 has posed tremendous challenges for the world and lessons to prepare the health workforce for public health crises and unexpected events/disasters. The pandemic has also uncovered the impact challenges are having on the mental health of healthcare providers. In this session, panellists will discuss these challenges, strategies related to interventions and supportive mechanisms in the area of mental health of the pharmaceutical workforce.


11:00 – 11:05      Introduction by the chair
11:05 – 11:20


Mental health, the impact on health professions: WHPA and the ways we can respond to our professions’ needs
Mr Howard Catton, International Council of Nurses (member of WHPA), Switzerland

11:20 – 11:35


Resilience of the pharmaceutical workforce pre, during and post the pandemic
Dr Catriona Bradley, Irish Institute of Pharmacy, Ireland
11:35 – 11:50


Suicide prevention: are pharmacy teams an overlooked and indispensable asset?
Dr Hayley Gorton, The University of Huddersfield, UK
11:50 – 12:20   Panel discussion and Q&A
12:20 – 12:30


Conclusion by the chair 

Learning Objectives

  1. To describe how the COVID-19 pandemic unmasked new and existing challenges in mental health among healthcare workers and frontliners including members of the pharmaceutical workforce
  2. To describe strategies and mechanisms implemented to address mental health issues of healthcare workers and frontliners including members of the pharmaceutical workforce from various stakeholders, professional bodies and government agencies
Back to top